Vir Biotechnology (VIR) Long-Term Investments (2018 - 2026)

Vir Biotechnology's Long-Term Investments history runs 9 years deep, the most recent figure standing at $333.0 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 52.64% year-over-year to $333.0 million; the TTM figure through Mar 2026 stood at $333.0 million (up 52.64% YoY), while the FY2025 annual figure was $314.6 million, up 65.55% from the prior year.
• Long-Term Investments came in at $333.0 million for Q1 2026 at Vir Biotechnology, up from $314.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $359.7 million in Q1 2024 to a low of $23.9 million in Q4 2022.
• A 5-year average of $180.2 million and a median of $190.0 million in 2024 frame the typical range for Long-Term Investments.
• On a YoY basis, Long-Term Investments climbed as much as 1612.02% in 2022 and fell as far as 88.12% in 2022.
• Vir Biotechnology's Long-Term Investments stood at $23.9 million in 2022, then soared by 339.98% to $105.3 million in 2023, then jumped by 80.49% to $190.0 million in 2024, then soared by 65.55% to $314.6 million in 2025, then gained by 5.85% to $333.0 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $333.0 million, $314.6 million, and $304.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison